cimetidine has been researched along with Plasma Cell Tumor in 2 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Van Ness, J | 1 |
Laemmli, UK | 1 |
Pettijohn, DE | 1 |
Gorczynski, RM | 1 |
Kennedy, M | 1 |
Ciampi, A | 1 |
2 other studies available for cimetidine and Plasma Cell Tumor
Article | Year |
---|---|
Immunization in vitro and production of monoclonal antibodies specific to insoluble and weakly immunogenic proteins.
Topics: Animals; Antibodies, Monoclonal; Antigen-Antibody Complex; B-Lymphocytes; Cell Line; Cimetidine; Epi | 1984 |
Cimetidine reverses tumor growth enhancement of plasmacytoma tumors in mice demonstrating conditioned immunosuppression.
Topics: Animals; Cimetidine; Conditioning, Classical; Cyclophosphamide; Drinking Behavior; Female; Histamine | 1985 |